- $12.8 BnWorld market, 2023
- $74.9 BnProjected, 2033
- 19.3%Growth a year (CAGR)
- 986Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$5.4 Bn
17.3% a year · 42% of the world -
2
China
$1 Bn
20.8% a year · 8% of the world -
3
Canada
$1 Bn
19.3% a year · 8% of the world -
4
Japan
$798 Mn
19.8% a year · 6.2% of the world -
5
Germany
$470 Mn
17.5% a year · 3.7% of the world -
6
France
$353 Mn
18.3% a year · 2.7% of the world -
7
UK
$334 Mn
17.3% a year · 2.6% of the world -
8
Brazil
$321 Mn
20.3% a year · 2.5% of the world -
9
Italy
$308 Mn
18.8% a year · 2.4% of the world -
10
Ecuador
$257 Mn
19.9% a year · 2% of the world
Most clinical trials
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)
SpainDigital diabetes care by country and region
India
Saudi Arabia
Mexico
Australia
South Africa
UAE
Egypt
Philippines
Hong Kong
Malaysia
Singapore
Thailand
Kenya
New Zealand
Russia"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 8,798 papers since 2021
- Advances in the hospital management of hyperglycemia and type 2 diabetes in non-critical care settings. BMJ open diabetes research & care, 2026
- Continuous Glucose Monitoring in Obesity Without Diabetes: An Unnecessary Gadget or a Gateway to Precision Care? Diabetes, obesity & metabolism, 2026
- Clinical Outcomes of Multidisciplinary Remote Patient Monitoring for Patients With Poorly Controlled Type 2 Diabetes: Retrospective Cohort Study. JMIR diabetes, 2026
- Guiding Inpatient Glycemic Management with Continuous Glucose Monitoring. A Prospective Nonrandomized Comparative Cohort Study. Diabetes therapy : research, treatment and education of diabetes and related disorders, 2026
- Healthcare professionals' experience with early-stage (stage 1 and 2) type 1 diabetes and readiness for immunotherapies in adults: A UK-based survey. Diabetic medicine : a journal of the British Diabetic Association, 2026
Patients: Diabetes (adults)
| Place | Value | Year |
|---|---|---|
| World | 14.1 | 2022 |
| Australia | 8.1 | 2022 |
| Brazil | 12.9 | 2022 |
| Canada | 6.8 | 2022 |
| China | 11.2 | 2022 |
| Ecuador | 12.7 | 2022 |
| Egypt | 27.8 | 2022 |
| France | 2.7 | 2022 |
| Germany | 6.6 | 2022 |
| India | 22.6 | 2022 |
| Italy | 7.2 | 2022 |
| Japan | 6.4 | 2022 |
| Kenya | 5.6 | 2022 |
| Malaysia | 26.7 | 2022 |
| Mexico | 14.3 | 2022 |
| New Zealand | 9.0 | 2022 |
| Philippines | 13.2 | 2022 |
| Russia | 8.1 | 2022 |
| Saudi Arabia | 20.8 | 2022 |
| Singapore | 13.1 | 2022 |
| South Africa | 13.9 | 2022 |
| Spain | 3.6 | 2022 |
| Thailand | 12.3 | 2022 |
| UAE | 26.1 | 2022 |
| UK | 8.8 | 2022 |
| US | 12.5 | 2022 |
Compare Digital diabetes care side by side
Key companies in Digital diabetes care
Dexcom, Inc.
F. Hoffmann-La Roche Ltd
Insulet Corporation
Medtronic Plc
Senseonics
Quick answers
How big is the Digital diabetes care market?
The world Digital diabetes care market was worth about $12.8 Bn in 2023 and is projected to reach $74.9 Bn by 2033, growing 19.3% a year (CAGR).
Which country has the largest Digital diabetes care market?
The US is the largest of the 24 countries we cover, at $5.4 Bn in 2023. India grows fastest, at 22.3% a year.
How many clinical trials are running in Digital diabetes care?
ClinicalTrials.gov lists 986 active trials worldwide (recruiting, about to start or running), most of them in the US, as of 10 Nov 2026.
How much research is published on Digital diabetes care?
PubMed lists about 8,798 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Patients: WHO Global Health Observatory. Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.